FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3021456027> ?p ?o ?g. }

• W3021456027 endingPage "1259" @default.
• W3021456027 startingPage "1249" @default.
• W3021456027 abstract "Estimate effects of ranibizumab on diabetic retinopathy (DR) severity in US Hispanic and non-Hispanic white persons with center-involved diabetic macular edema (DME) causing vision impairment for whom ranibizumab treatment would be considered.This model simulated DR severity outcomes over 2 years in the better-seeing eye using US census, National Health and Nutrition Examination Survey, Wisconsin Epidemiologic Study of Diabetic Retinopathy, and Los Angeles Latino Eye Study data. Baseline DR severity estimated from Diabetic Retinopathy Clinical Research Network trial data. Changes in DR severity after 2 years, with/without monthly ranibizumab (0.3 or 0.5 mg), were estimated from Phase III clinical trial data (RIDE/RISE) using a 2-dimensional Monte Carlo simulation model. Number of patients over a 2-year period for whom 1) DR severity worsening was avoided, 2) DR severity improved, and 3) selected clinical events related to proliferative DR (PDR) occurred, was estimated.An estimated 37,274 US Hispanic and non-Hispanic white persons were projected to have DR with center-involved DME and be eligible for ranibizumab treatment. The number of persons with moderately severe non-proliferative DR (NPDR) or less severe DR at baseline who would worsen to PDR and experience a PDR complication over 2 years would be reduced from 437 with no ranibizumab to 19 with ranibizumab (95% reduction; 95% simulation interval [SI], 79-100%). The number of persons with severe NPDR or less severe DR at baseline who would be expected to improve by ≥2 DR severity levels over 2 years would increase from 1706 with no ranibizumab to 13,042 with ranibizumab (682% increase; 95% SI, 478-967%).This model estimates that ranibizumab treatment in US Hispanic and non-Hispanic white patients with center-involved DME causing vision impairment would potentially reduce the number of patients with worsening DR and potentially increase the number with DR improvements." @default.
• W3021456027 created "2020-05-13" @default.
• W3021456027 creator A5004182595 @default.
• W3021456027 creator A5006260782 @default.
• W3021456027 creator A5018773741 @default.
• W3021456027 creator A5024474312 @default.
• W3021456027 creator A5039879095 @default.
• W3021456027 creator A5046921541 @default.
• W3021456027 creator A5053891791 @default.
• W3021456027 creator A5067278845 @default.
• W3021456027 creator A5083440287 @default.
• W3021456027 date "2020-05-01" @default.
• W3021456027 modified "2023-09-23" @default.
• W3021456027 title "<p>Diabetic Population-Based Model to Estimate Impact of Ranibizumab on Diabetic Retinopathy Severity in Patients with Diabetic Macular Edema</p>" @default.
• W3021456027 cites W1525145190 @default.
• W3021456027 cites W1560522926 @default.
• W3021456027 cites W1782108791 @default.
• W3021456027 cites W1975553413 @default.
• W3021456027 cites W1995827762 @default.
• W3021456027 cites W1997643874 @default.
• W3021456027 cites W1999957425 @default.
• W3021456027 cites W2020865074 @default.
• W3021456027 cites W2022886290 @default.
• W3021456027 cites W2041485080 @default.
• W3021456027 cites W2049036672 @default.
• W3021456027 cites W2057789225 @default.
• W3021456027 cites W2059755869 @default.
• W3021456027 cites W2087904667 @default.
• W3021456027 cites W2096257972 @default.
• W3021456027 cites W2096648979 @default.
• W3021456027 cites W2138480916 @default.
• W3021456027 cites W2143094951 @default.
• W3021456027 cites W2148477686 @default.
• W3021456027 cites W2171946822 @default.
• W3021456027 cites W2177844192 @default.
• W3021456027 cites W2178156144 @default.
• W3021456027 cites W2560206371 @default.
• W3021456027 cites W2594336900 @default.
• W3021456027 cites W2607606893 @default.
• W3021456027 cites W2616361514 @default.
• W3021456027 cites W2767261857 @default.
• W3021456027 cites W2894823502 @default.
• W3021456027 cites W4240531687 @default.
• W3021456027 cites W4299436089 @default.
• W3021456027 doi "https://doi.org/10.2147/opth.s236636" @default.
• W3021456027 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7213867" @default.
• W3021456027 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32440092" @default.
• W3021456027 hasPublicationYear "2020" @default.
• W3021456027 type Work @default.
• W3021456027 sameAs 3021456027 @default.
• W3021456027 citedByCount "1" @default.
• W3021456027 countsByYear W30214560272023 @default.
• W3021456027 crossrefType "journal-article" @default.
• W3021456027 hasAuthorship W3021456027A5004182595 @default.
• W3021456027 hasAuthorship W3021456027A5006260782 @default.
• W3021456027 hasAuthorship W3021456027A5018773741 @default.
• W3021456027 hasAuthorship W3021456027A5024474312 @default.
• W3021456027 hasAuthorship W3021456027A5039879095 @default.
• W3021456027 hasAuthorship W3021456027A5046921541 @default.
• W3021456027 hasAuthorship W3021456027A5053891791 @default.
• W3021456027 hasAuthorship W3021456027A5067278845 @default.
• W3021456027 hasAuthorship W3021456027A5083440287 @default.
• W3021456027 hasBestOaLocation W30214560271 @default.
• W3021456027 hasConcept C118487528 @default.
• W3021456027 hasConcept C126322002 @default.
• W3021456027 hasConcept C134018914 @default.
• W3021456027 hasConcept C2776694085 @default.
• W3021456027 hasConcept C2777802072 @default.
• W3021456027 hasConcept C2779829184 @default.
• W3021456027 hasConcept C2781100027 @default.
• W3021456027 hasConcept C2908647359 @default.
• W3021456027 hasConcept C2985127711 @default.
• W3021456027 hasConcept C535046627 @default.
• W3021456027 hasConcept C555293320 @default.
• W3021456027 hasConcept C71924100 @default.
• W3021456027 hasConcept C99454951 @default.
• W3021456027 hasConceptScore W3021456027C118487528 @default.
• W3021456027 hasConceptScore W3021456027C126322002 @default.
• W3021456027 hasConceptScore W3021456027C134018914 @default.
• W3021456027 hasConceptScore W3021456027C2776694085 @default.
• W3021456027 hasConceptScore W3021456027C2777802072 @default.
• W3021456027 hasConceptScore W3021456027C2779829184 @default.
• W3021456027 hasConceptScore W3021456027C2781100027 @default.
• W3021456027 hasConceptScore W3021456027C2908647359 @default.
• W3021456027 hasConceptScore W3021456027C2985127711 @default.
• W3021456027 hasConceptScore W3021456027C535046627 @default.
• W3021456027 hasConceptScore W3021456027C555293320 @default.
• W3021456027 hasConceptScore W3021456027C71924100 @default.
• W3021456027 hasConceptScore W3021456027C99454951 @default.
• W3021456027 hasLocation W30214560271 @default.
• W3021456027 hasLocation W30214560272 @default.
• W3021456027 hasLocation W30214560273 @default.
• W3021456027 hasLocation W30214560274 @default.
• W3021456027 hasOpenAccess W3021456027 @default.
• W3021456027 hasPrimaryLocation W30214560271 @default.
• W3021456027 hasRelatedWork W1977529774 @default.
• W3021456027 hasRelatedWork W2062091766 @default.
• W3021456027 hasRelatedWork W2087604601 @default.

• next